The Quality Management Ecosystem in Cell Therapy in Catalonia (Spain): An Opportunity for Integrating Standards and Streamlining Quality Compliance

Other authors

Institut Català de la Salut

[Vives J] Banc de Sang i Teixits, Edifici Dr. Frederic Duran i Jordà, Barcelona, Spain. Grup de Recerca en Enginyeria Tissular Musculoesquelètica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Sòria MG] Banc de Sang i Teixits, Barcelona, Spain. [McGrath E] International Council for Commonality in Blood Banking Automation (ICCBBA), San Bernardino, USA. [Magri M] ASST Papa Giovanni XXIII, Bergamo, Italy

Vall d'Hebron Barcelona Hospital Campus

Publication date

2022-09-14T08:08:29Z

2022-09-14T08:08:29Z

2022-07-05



Abstract

Integrated management system; Quality compliance; Quality standards


Sistema de gestión integrado; Cumplimiento de la calidad; Estándares de calidad


Sistema de gestió integrat; Compliment de la qualitat; Estàndards de qualitat


Cell therapies are required to meet with compulsory regulations that co-exist with other optional standards and guidelines that together compose a complex quality management system. Indeed, reliable insights on the mechanisms of action and safety of novel cell-based therapies require adherence to solid quality management structures in all steps of the value chain, from early research and tissue procurement to clinical trials and biovigilance, thus guaranteeing reproducibility and solid foundations for better science and improved clinical practice. Herein we present the concept of the quality ecosystem as a tool to understand and assist all stakeholders involved in developing and structuring the integration of standards as novel developments are taking place. We conclude that the various quality management initiatives can all be thought about under the umbrella of an ecosystem.


Work in JV’s laboratory is supported by the Spanish Advanced Therapy Network (TERAV, expedient No. RD21/0017/0022), awarded by the Generalitat de Catalunya as Consolidated Research Group (ref. 2017SGR719) and funded by Ministerio de Ciencia Innovación y Universidades de España (Instituto de Salud Carlos III, expedient No. PI19/01788).

Document Type

Article


Published version

Language

English

Publisher

MDPI

Related items

Cells;11(13)

https://doi.org/10.3390/cells11132112

info:eu-repo/grantAgreement/ES/PE2017-2020/RD21%2F0017%2F0022

info:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F01788

Recommended citation

This citation was generated automatically.

Rights

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)